交易 PURETECH HEALTH PLC ORD 1P - PRTC CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.0240 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.025266% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003348% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | GBP | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United Kingdom of Great Britain and Northern Ireland | ||||||||
交易费 | 0% |
*Information provided by Capital.com
PureTech Health PLC ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 2.2405 | 0.0400 | 1.82% | 2.2005 | 2.2455 | 2.1605 |
Mar 26, 2024 | 2.1755 | -0.0650 | -2.90% | 2.2405 | 2.2955 | 2.1755 |
Mar 25, 2024 | 2.2355 | 0.1195 | 5.65% | 2.1160 | 2.2855 | 2.1160 |
Mar 22, 2024 | 2.1560 | -0.0045 | -0.21% | 2.1605 | 2.1660 | 2.0660 |
Mar 21, 2024 | 2.1510 | -0.0245 | -1.13% | 2.1755 | 2.2055 | 2.1210 |
Mar 20, 2024 | 2.1655 | -0.0800 | -3.56% | 2.2455 | 2.2455 | 2.1510 |
Mar 19, 2024 | 2.2055 | 0.0695 | 3.25% | 2.1360 | 2.2405 | 2.1110 |
Mar 18, 2024 | 2.0010 | 0.0750 | 3.89% | 1.9260 | 2.0410 | 1.9240 |
Mar 15, 2024 | 1.9520 | 0.0040 | 0.21% | 1.9480 | 1.9820 | 1.9300 |
Mar 14, 2024 | 1.9760 | 0.0300 | 1.54% | 1.9460 | 1.9960 | 1.9020 |
Mar 13, 2024 | 1.9360 | -0.0460 | -2.32% | 1.9820 | 2.0510 | 1.9360 |
Mar 12, 2024 | 1.9840 | 0.0560 | 2.90% | 1.9280 | 2.0160 | 1.9280 |
Mar 11, 2024 | 1.9000 | 0.0020 | 0.11% | 1.8980 | 1.9420 | 1.8880 |
Mar 8, 2024 | 1.9200 | 0.0420 | 2.24% | 1.8780 | 1.9440 | 1.8580 |
Mar 7, 2024 | 1.8880 | -0.0100 | -0.53% | 1.8980 | 1.9820 | 1.8720 |
Mar 6, 2024 | 1.9340 | 0.0380 | 2.00% | 1.8960 | 1.9740 | 1.8520 |
Mar 5, 2024 | 1.8860 | -0.0120 | -0.63% | 1.8980 | 1.9640 | 1.8780 |
Mar 4, 2024 | 1.9520 | -0.0140 | -0.71% | 1.9660 | 2.0110 | 1.9520 |
Mar 1, 2024 | 1.9940 | 0.0460 | 2.36% | 1.9480 | 2.0260 | 1.9120 |
Feb 29, 2024 | 1.9720 | -0.0040 | -0.20% | 1.9760 | 2.0060 | 1.9240 |
PURETECH HEALTH PLC ORD 1P Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Thursday, April 25, 2024 | ||
时间(协调世界时) (UTC) 06:00 | 国家 US
| 事件 Full Year 2023 PureTech Health PLC Earnings Release Full Year 2023 PureTech Health PLC Earnings ReleaseForecast(预报) -上一页 - |
Wednesday, June 12, 2024 | ||
时间(协调世界时) (UTC) 15:00 | 国家 US
| 事件 PureTech Health PLC Annual Shareholders Meeting PureTech Health PLC Annual Shareholders MeetingForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 15.618 | 17.388 | 11.768 | 9.807 | 20.748 |
收入 | 15.618 | 17.388 | 11.768 | 9.807 | 20.748 |
總營業費用 | 166.344 | 167.67 | 131.299 | -521.847 | 114.221 |
銷售/一般/行政費用,總計 | 60.991 | 57.199 | 49.44 | 59.358 | 47.365 |
研究與開發 | 152.433 | 110.471 | 81.859 | 85.848 | 77.402 |
異常費用(收入) | -47.081 | 0 | 0 | -667.053 | -10.546 |
營業收入 | -150.726 | -150.282 | -119.531 | 531.654 | -93.473 |
利息收入(費用),非經營淨值 | -80.512 | 81.55 | 141.701 | -18.634 | 21.253 |
其他,淨值 | 138.455 | 9.779 | -3.171 | -34.464 | -0.278 |
稅前淨收入 | -92.783 | -58.953 | 18.969 | 478.474 | -68.438 |
稅後淨收入 | -37.064 | -62.709 | 4.568 | 366.065 | -70.659 |
少數股東權益 | -13.29 | 2.151 | 1.417 | 55.079 | 27.005 |
未計算非常項目前的淨收益 | -50.354 | -60.558 | 5.985 | 421.144 | -43.654 |
淨收入 | -50.354 | -60.558 | 5.985 | 421.144 | -43.654 |
普通股股東可獲收益 (不含非經常性項目) | -50.354 | -60.558 | 5.985 | 421.144 | -43.654 |
普通股股東可獲收益 (含非經常性項目) | -50.354 | -60.558 | 5.985 | 421.144 | -43.654 |
攤薄淨收入 | -50.354 | -60.558 | 5.985 | 421.144 | -43.654 |
攤薄後加權平均股 | 287.797 | 286.591 | 292.856 | 283.426 | 273.848 |
扣除特別項目的每股攤薄盈利 | -0.17496 | -0.2113 | 0.02044 | 1.4859 | -0.15941 |
每股正常攤薄盈利 | -0.2813 | -0.2113 | 0.0205 | -0.0437 | -0.19408 |
Gain (Loss) on Sale of Assets | -0.03 | -0.082 | 4.06 | ||
攤薄調整 | |||||
Other Operating Expenses, Total | 0.001 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
總收入 | 3.15 | 8.588 | 7.03 | 11.552 | 5.836 |
收入 | 3.15 | 8.588 | 7.03 | 11.552 | 5.836 |
總營業費用 | 17.526 | 113.736 | 52.608 | 93.754 | 73.916 |
銷售/一般/行政費用,總計 | 26.166 | 37.347 | 23.644 | 31.613 | 25.586 |
研究與開發 | 53.146 | 67.854 | 84.579 | 62.141 | 48.33 |
異常費用(收入) | -61.787 | 8.533 | -55.614 | 0 | |
營業收入 | -14.376 | -105.148 | -45.578 | -82.202 | -68.08 |
利息收入(費用),非經營淨值 | 2.875 | -7.841 | -72.671 | 96.406 | -14.856 |
Gain (Loss) on Sale of Assets | |||||
其他,淨值 | -2.243 | 76.163 | 62.292 | 21.774 | -11.995 |
稅前淨收入 | -13.744 | -36.826 | -55.957 | 35.978 | -94.931 |
稅後淨收入 | -25.551 | -13.592 | -23.472 | 14.844 | -77.553 |
少數股東權益 | 0.546 | -8.418 | -4.872 | -0.007 | 2.158 |
未計算非常項目前的淨收益 | -25.005 | -22.01 | -28.344 | 14.837 | -75.395 |
淨收入 | -25.005 | -22.01 | -28.344 | 14.837 | -75.395 |
普通股股東可獲收益 (不含非經常性項目) | -25.004 | -22.01 | -28.344 | 14.837 | -75.395 |
普通股股東可獲收益 (含非經常性項目) | -25.004 | -22.01 | -28.344 | 14.837 | -75.395 |
攤薄淨收入 | -25.004 | -22.01 | -28.344 | 14.837 | -75.395 |
攤薄後加權平均股 | 278.254 | 287.839 | 287.754 | 287.171 | 286.011 |
扣除特別項目的每股攤薄盈利 | -0.08986 | -0.07647 | -0.0985 | 0.05167 | -0.26361 |
每股正常攤薄盈利 | -0.23419 | -0.0572 | -0.22413 | 0.05167 | -0.26361 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Other Operating Expenses, Total | 0.001 | 0.002 | -0.001 | ||
Total Adjustments to Net Income | 0.001 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 386.192 | 501.809 | 414.348 | 168.845 | 259.786 |
現金和短期投資 | 352.219 | 467.832 | 406.005 | 164.572 | 253.078 |
現金等價物 | 149.866 | 465.708 | 403.881 | 132.36 | 117.051 |
短期投資 | 202.353 | 2.124 | 2.124 | 32.212 | 136.027 |
應收賬款總額,淨額 | 22.357 | 23.223 | 2.939 | 2.327 | 1.328 |
應收賬款 - 貿易,淨額 | 11.867 | 3.174 | 2.558 | 1.977 | 1.328 |
預付的費用 | 11.617 | 10.755 | 5.405 | 1.946 | 5.38 |
總資産 | 702.647 | 946.006 | 989.994 | 941.178 | 441.763 |
物業/廠房/設備,總計 - 淨額 | 37.238 | 43.937 | 42.875 | 43.838 | 8.323 |
物業/廠房/設備,總計 - 總額 | 57.318 | 58.282 | 53.395 | 51.03 | 14.388 |
累計折舊,總計 | -20.08 | -14.345 | -10.521 | -7.192 | -6.065 |
無形資産,淨額 | 0.831 | 0.987 | 0.899 | 0.625 | 3.08 |
長期投資 | 261.039 | 397.179 | 530.161 | 725.547 | 169.755 |
其他長期資産,總計 | 0.011 | 0.809 | 0.011 | 0.241 | 0.819 |
流動負債總額 | 96.885 | 226.135 | 180.924 | 139.201 | 265.764 |
應付賬款 | 26.504 | 11.346 | 8.871 | 11.098 | 4.644 |
預提費用 | 26.323 | 22.012 | 9.09 | 8.744 | 11.231 |
應付票據/短期債務 | 2.345 | 3.916 | 26.455 | 1.455 | 12.01 |
其他流動負債,總計 | 31.586 | 184.055 | 133.248 | 114.975 | 237.879 |
負債總額 | 160.427 | 352.491 | 320.246 | 273.14 | 166.256 |
長期債務總額 | 34.399 | 43.301 | 46.906 | 34.914 | 0 |
少數股權 | 5.369 | -9.368 | -16.209 | -17.64 | -108.535 |
其他負債,總計 | 4.129 | 2.658 | -0.001 | 1.22 | 2.599 |
總權益 | 542.22 | 593.515 | 669.748 | 668.038 | 275.507 |
普通股 | 5.455 | 5.444 | 5.417 | 5.408 | 5.375 |
額外實收資本 | 289.624 | 289.303 | 288.978 | 287.962 | 278.385 |
留存收益(累計赤字) | 273.544 | 298.3 | 374.885 | 374.668 | -8.263 |
其他權益,總計 | 0.089 | 0.468 | 0.468 | 0 | 0.01 |
總負債和股東權益 | 702.647 | 946.006 | 989.994 | 941.178 | 441.763 |
已發行普通股總數 | 289.162 | 287.797 | 285.885 | 285.371 | 282.494 |
遞延所得稅 | 19.645 | 89.765 | 108.626 | 115.445 | 6.428 |
應收票據 - 長期 | 17.336 | 1.285 | 1.7 | 2.082 | |
長期債務的當前部分/資本租賃 | 10.128 | 4.807 | 3.261 | 2.929 | |
資本租賃義務 | 24.155 | 29.04 | 32.088 | 34.914 | |
其他流動資産,總計 | -0.001 | -0.001 | -0.001 | ||
Payable/Accrued | -0.001 | -0.001 | -0.001 | ||
長期債務 | 10.244 | 14.261 | 14.818 | ||
Treasury Stock - Common | -26.492 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
流動資産總額 | 360.099 | 386.192 | 381.811 | 501.809 | 451.057 |
現金和短期投資 | 352.139 | 352.219 | 368.034 | 467.832 | 441.89 |
現金等價物 | 350.515 | 149.866 | 365.91 | 465.708 | 439.766 |
短期投資 | 1.624 | 202.353 | 2.124 | 2.124 | 2.124 |
應收賬款總額,淨額 | 2.301 | 22.357 | 9.315 | 23.223 | 3.836 |
應收賬款 - 貿易,淨額 | 2.102 | 11.867 | 4.369 | 3.174 | 3.438 |
預付的費用 | 5.659 | 11.617 | 4.463 | 10.755 | 5.331 |
總資産 | 693.552 | 702.647 | 823.153 | 946.006 | 896.883 |
物業/廠房/設備,總計 - 淨額 | 21.497 | 37.238 | 41.399 | 43.937 | 41.953 |
物業/廠房/設備,總計 - 總額 | 57.318 | 58.43 | 58.282 | 54.62 | |
累計折舊,總計 | -20.08 | -17.03 | -14.345 | -12.667 | |
無形資産,淨額 | 0.931 | 0.831 | 0.968 | 0.987 | 0.898 |
長期投資 | 285.204 | 261.039 | 397.899 | 397.179 | 401.468 |
應收票據 - 長期 | 24.865 | 17.336 | 1.065 | 1.285 | 1.497 |
其他長期資産,總計 | 0.956 | 0.011 | 0.011 | 0.809 | 0.01 |
流動負債總額 | 49.265 | 96.885 | 150.254 | 226.135 | 213.948 |
Payable/Accrued | -0.001 | -0.001 | -0.001 | 35.817 | 39.85 |
應付票據/短期債務 | 0 | 2.345 | 1.455 | 3.916 | 28.69 |
長期債務的當前部分/資本租賃 | 5.58 | 10.128 | 8.064 | 4.807 | 3.46 |
其他流動負債,總計 | 12.439 | 31.586 | 109.816 | 181.595 | 141.948 |
負債總額 | 179.883 | 160.427 | 241.396 | 352.491 | 328.886 |
長期債務總額 | 19.996 | 34.399 | 38.578 | 43.301 | 45.437 |
資本租賃義務 | 19.996 | 24.155 | 26.697 | 29.04 | 30.463 |
遞延所得稅 | 9.084 | 19.645 | 57.277 | 89.765 | 74.468 |
少數股權 | -4.778 | 5.369 | -5.733 | -9.368 | -6.625 |
其他負債,總計 | 106.316 | 4.129 | 1.02 | 2.658 | 1.658 |
總權益 | 513.669 | 542.22 | 581.757 | 593.515 | 567.997 |
普通股 | 5.461 | 5.455 | 5.446 | 5.444 | 5.419 |
額外實收資本 | 290.262 | 289.624 | 289.301 | 289.303 | 289.013 |
留存收益(累計赤字) | 250.869 | 273.544 | 291.345 | 298.3 | 273.097 |
其他權益,總計 | 0.182 | 0.089 | -0.068 | 0.468 | 0.468 |
總負債和股東權益 | 693.552 | 702.647 | 823.153 | 946.006 | 896.883 |
已發行普通股總數 | 289.162 | 289.162 | 287.797 | 287.797 | 286.531 |
其他流動資産,總計 | -0.001 | -0.001 | -0.001 | ||
長期債務 | 0 | 10.244 | 11.881 | 14.261 | 14.974 |
應付賬款 | 8.725 | 26.504 | 15.094 | ||
預提費用 | 22.522 | 26.323 | 15.826 | ||
Treasury Stock - Common | -33.105 | -26.492 | -4.267 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -37.065 | -62.709 | 4.568 | 366.065 | -70.659 |
经营活动产生的现金 | -178.793 | -158.274 | -131.827 | -98.156 | -72.796 |
经营活动产生的现金 | 8.893 | 7.287 | 6.645 | 6.665 | 2.778 |
非现金物品 | -145.939 | -72.779 | -112.281 | -599.144 | -16.602 |
营运资金的变化 | -4.682 | -30.073 | -30.759 | 16.181 | 9.964 |
投资活动产生的现金 | -107.223 | 197.375 | 364.478 | 63.659 | -39.645 |
资本支出 | -2.176 | -5.661 | -5.424 | -12.538 | -4.49 |
其他投资现金流量项目,总计 | -105.047 | 203.036 | 369.902 | 76.197 | -35.155 |
融资活动产生的现金 | -29.826 | 22.726 | 38.869 | 49.91 | 156.887 |
融资现金流项目 | -0.041 | -14.142 | -12.889 | -1.28 | -1.07 |
股票的发行(报废),净额 | -26.153 | 38.028 | 14.878 | 51.552 | 151.995 |
债务的发行(退还),净额 | -3.632 | -1.16 | 36.88 | -0.25 | 5.962 |
外汇效应 | 0 | 0 | -0.104 | -0.044 | |
现金净变化 | -315.842 | 61.827 | 271.52 | 15.309 | 44.402 |
Deferred Taxes | 112.077 | 1.723 | |||
已付现金利息 | 3.366 | 3.382 | 2.651 | 2.495 | |
Total Cash Dividends Paid | 0 | 0 | -0.112 | ||
Cash Taxes Paid | 20.696 | 27.766 | 20.737 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | -37.065 | -23.472 | -62.709 | -77.553 | 4.568 |
Cash From Operating Activities | -178.793 | -87.249 | -158.274 | -65.366 | -131.827 |
Cash From Operating Activities | 8.893 | 4.294 | 7.287 | 3.648 | 6.645 |
Deferred Taxes | |||||
Non-Cash Items | -145.939 | -74.093 | -72.779 | 15.636 | -112.281 |
Cash Interest Paid | 3.366 | 1.633 | 3.382 | 1.705 | 2.651 |
Changes in Working Capital | -4.682 | 6.022 | -30.073 | -7.097 | -30.759 |
Cash From Investing Activities | -107.223 | -6.884 | 197.375 | 114.964 | 364.478 |
Capital Expenditures | -2.176 | -1.647 | -5.661 | -2.724 | -5.424 |
Other Investing Cash Flow Items, Total | -105.047 | -5.237 | 203.036 | 117.688 | 369.902 |
Cash From Financing Activities | -29.826 | -5.665 | 22.726 | -13.713 | 38.869 |
Financing Cash Flow Items | -0.041 | -0.004 | -14.142 | -13.746 | -12.889 |
Total Cash Dividends Paid | 0 | 0 | |||
Issuance (Retirement) of Stock, Net | -26.153 | -4.26 | 38.028 | 0.043 | 14.878 |
Issuance (Retirement) of Debt, Net | -3.632 | -1.401 | -1.16 | -0.01 | 36.88 |
Foreign Exchange Effects | 0 | 0 | 0 | ||
Net Change in Cash | -315.842 | -99.798 | 61.827 | 35.885 | 271.52 |
Cash Taxes Paid | 20.696 | 0 | 27.766 | 3.364 | 20.737 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Puretech Health plc Company profile
关于 Puretech Health PLC
PureTech Health PLC是一家临床阶段的生物治疗公司。 公司致力于发现、开发和商业化治疗破坏性疾病的药物,包括炎症、纤维化和免疫病症、难治性癌症、淋巴和胃肠道疾病、以及神经和神经心理疾病等。 公司的管线由27种治疗方法和候选治疗药物组成,其中包括两个已经获得美国食品和药物管理局(FDA)许可和欧洲上市授权的药物。 公司的全资管道包括六个候选治疗药物,包括LYT-100、LYT-200、LYT-210、LYT-300、LYT-500、LYT-510和LYT-503/IMB-150。 其部门包括内部、受控成立实体、非受控成立实体和母公司及其他。 内部部门正在推进全资项目,重点是免疫学、纤维化和淋巴系统疾病。
Industry: | Biotechnology & Medical Research (NEC) |
6 Tide Street
Suite 400
BOSTON
MASSACHUSETTS 02210
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球580,000万多名交易者的一份子,选择利用Capital.com进行交易吧。